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Summary
Sclerosteosis is an uncommon, autosomal recessive, pro-
gressive, sclerosing, bone dysplasia characterized by gen-
eralized osteosclerosis and hyperostosis of the skeleton,
affecting mainly the skull and mandible. In most patients
this causes facial paralysis and hearing loss. Other fea-
tures are gigantism and hand abnormalities. In the pre-
sent study, linkage analysis in two consanguineous fam-
ilies with sclerosteosis resulted in the assignment of the
sclerosteosis gene to chromosome 17q12-q21. This re-
gion was analyzed because of the recent assignment to
this chromosomal region of the gene causing van
Buchem disease, a rare autosomal recessive condition
with a hyperostosis similar to sclerosteosis. Because of
the clinical similarities between sclerosteosis and van
Buchem disease, it has previously been suggested that
both conditions might be caused by mutations in the
same gene. Our study now provides genetic evidence for
this hypothesis.
Introduction
Sclerosteosis (MIM 269500) is a rare autosomal reces-
sive disorder that is classified, according to Beighton
(1988), among the craniotubular hyperostoses. The dis-
order was first thought to be a variant of osteopetrosis,
until Hansen introduced the term “sclerosteosis” in
1967 (Hansen 1967). Sclerosteosis is characterized by
bony overgrowth of the skull, the mandible, and the
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tubular bones, resulting in a very thick calvarium with
macrocephaly and an enlarged mandible. The cortices
of the long bones are thickened, and vertebral pedicles,
ribs, and pelvis are dense. Skeletal deformities do not
occur at birth but become noticeable at ∼5 years of age
and progress steadily thereafter (Nager et al. 1983).
Fractures have never been described in patients with scle-
rosteosis. Recurrent facial-nerve palsy, deafness, and op-
tic atrophy because of narrowing of the cranial foramina
are frequent complications. Severe headaches can occur
as a result of raised intracranial pressure, which may
also lead to sudden death (Beighton et al. 1976; Nager
et al. 1983). Additional features of sclerosteosis are ex-
cessive height—sometimes even gigantism (Beighton et
al. 1984)—and hand abnormalities, including syndac-
tyly of the digits, radial deviation of the terminal pha-
langes, and dysplastic or absent nails. These hand ab-
normalities are congenital and make an early diagnosis
possible; moreover, they help to differentiate sclerosteo-
sis from other dysplasias in the group of craniotubular
hyperostoses.
Stein et al. (1983) performed a pathophysiological
analysis and showed a significantly increased bone-
formation rate but no osteoclast-related abnormalities.
Therefore, they postulated that sclerosteosis is primarily
a disorder of osteoblast hyperactivity.
Most patients with sclerosteosis are found in the Af-
rikaner community in South Africa, with 140 patients
described (Beighton et al. 1984). Other cases of scle-
rosteosis are a kindred in New York (Higinbotham and
Alexander 1941), a kindred of mixed ancestry in Mar-
yland (Kelly and Lawlah 1946; Witkop 1961, 1965;
Stein et al. 1983), a consanguineous family from Brazil
(Paes-Alves et al. 1982), and single patients from Swit-
zerland (Pietruscka 1958), Japan (Sugiura and Yasuhara
1975), Spain (Bueno et al. 1994), and Senegal (Tacconi
et al. 1998).
The clinical picture of patients suffering from scle-
rosteosis closely resembles that of van Buchem disease
1662 Am. J. Hum. Genet. 64:1661–1669, 1999
(MIM 239100). Patients with the latter disorder have a
generalized increased cortical thickness and an enlarged
jaw. The increased thickness of the skull causes facial-
nerve palsy and neurological complications because of
cranial-nerve entrapment (van Buchem et al. 1976). The
radiological findings in patients with van Buchemdisease
are very similar to those seen in patients with scleros-
teosis. The major differences between the two conditions
are the gigantism and the hand abnormalities, which are
seen in most patients with sclerosteosis but never in pa-
tients with van Buchem disease. Beighton et al. (1984)
postulated that van Buchem disease and sclerosteosis are
allelic conditions, caused by mutations in the same gene.
The prevalence of van Buchem disease worldwide is also
low, with 15 patients of Dutch origin (Van Buchem et
al. 1976; Van Hul et al. 1998), one family with four
affected siblings (Dixon et al. 1982), and a few isolated
cases (Lopez et al. 1985; Miguez et al. 1986; Fryns and
Van der Berghe 1988; Cook et al. 1989; Bettini et al.
1991). In the literature, a diagnosis of van Buchem dis-
ease has been made in pedigrees with a mild or asymp-
tomatic autosomal dominant hyperostosis (Maroteaux
et al. 1971; Dyson 1972; Lapresle et al. 1976; Owen
1976; Vayssairat et al. 1976; Gelman 1977; Gorlin and
Glass 1977; Ruckert et al. 1985; Perez-Vicente et al.
1987; Schendel 1988; Rodriguez et al. 1995), a condi-
tion first described by Worth and Wollin (1966).
Recently, we localized the gene responsible for van
Buchem disease to chromosome 17q12–q21, through a
genomewide search with highly polymorphic microsat-
ellite markers (Van Hul et al. 1998). All 11 patients
included in the present study live in a small ethnic isolate
in the Netherlands and share a common ancestor from
the 18th century. The van Buchem gene was subse-
quently mapped in an interval of 0.7 cM between genetic
markers D17S1787 (proximal) and D17S934 (distal).
The localization of the van Buchem gene to chromosome
17 allowed us to test whether sclerosteosis and van
Buchem disease are linked to the same chromosomal
region, which would suggest that the conditions are al-
lelic, or whether they are caused by mutations in dif-
ferent genes.
Families and Methods
Families
We ascertained members of two previously described
families with sclerosteosis, one from Brazil (Paes-Alves
et al. 1982) and one from Maryland (Kelly and Lawlah
1946; Witkop 1961, 1965; Stein et al. 1983). Venous
blood samples were acquired for DNA isolation after
informed consent was obtained (National Institutes of
Health protocol 77-CH-0070).
Paes-Alves et al. (1982) reported a family fromTucano
in the State of Bahia, Brazil, with six cases of scleros-
teosis, two of which were studied. We reanalyzed data
from this family (fig. 1a) and studied two previously
undescribed patients, IV-1 and V-7. Both cases from the
study by Paes-Alves et al. (1982) are deceased (fig. 1a,
cases A and B). Four other family members, two of
whom are dead, were reported to be affected, bringing
the total number of affected individuals in this pedigree
to eight. The genealogy of the family showed a highly
inbred pedigree (fig. 1a) with a common ancestor pair
for seven of the eight patients. So far, evidence that the
father of patient V-7 has the same ancestor is still miss-
ing. The family members were examined clinically and
radiologically, to ensure a reliable diagnosis. Patient V-
7, a 30-year-old woman, presented with a square face
with little expression, midfacial hypoplasia with a hy-
poplastic nasal bridge, high forehead, hypertelorism,
proptosis, prognatism, and a large mandible (fig. 2a and
b). Her hands showed cutaneous syndactyly of left digits
2 and 3, radial deviation of the terminal phalanx and a
hypoplastic nail on right digit 2, and diffuse thickening
of the phalanges bilaterally (fig. 2c). Radiographs of the
skull indicated thickening of the calvarium and facial
bones, with obliteration of the paranasal sinuses and
mastoid cells. A radiograph of the hands showed diffuse
thickening of the cortex of phalanges and metacarpals
with stenosis of the medullary canal. Patient IV-1, a 69-
year-old man, presented with similar facial changes, al-
though these were less prominent (fig. 2d). He is deaf
and blind and suffers from intense headaches. He has
bilateral partial cutaneous syndactyly on digits 2–4, a
dysplastic nail on left digit 2, clinodactyly with radial
deviation of the terminal phalanx of right digits 2 and
3, and bilateral camptodactyly of digit 5.
The American family has previously been studied by
Stein et al. (1983), who reported seven cases of scleros-
teosis in a triracial (white, American Indian, and black)
isolate in southern Maryland. Five individuals—two pa-
tients and three nonaffected individuals—are included
in this study. All individuals have a common ancestor,
with patient V-2 being an uncle of patient VI-1 (fig. 1b).
Patient V-2 (fig. 3a and b), a 64-year-old man, noted
bilateral hearing loss and bilateral facial paralysis and
suffered from headaches. He is quite debilitated, with
poor fine-motor functions. The patient has nail dysplasia
but no finger syndactyly. Exophthalmos, mild strabismus
(extropia), diplopia, and gigantism are present. Radio-
graphs indicated sclerosis of the skull and lateral wid-
ening of the mandible, with cortical thickening and ab-
normal diaphyseal modeling in the tubular bones. A
computed tomography (CT) scan of the posterior fossa
(fig. 3c) indicated marked thickening of the skull base,
with obliteration of the diploic space. Patient VI-1, a 21-
year-old man, was examined at age 5 years by Stein et
al. (1983), but at that time he was too young to present
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Figure 1 Pedigrees of families studied. Males are represented by squares, females by circles. Blackened symbols represent affected indi-
viduals. For the studied individuals, the haplotypes are given for the markers shown on the left. The haplotype segregating with the disease is
indicated by a blackened bar. a, Pedigree of Brazilian family with sclerosteosis. Patients A and B were studied by Paes-Alves et al. (1982). b,
Pedigree of American family.
the full picture of sclerosteosis. He now has bilateral
facial paralysis, hearing and vision loss on the left side,
exophthalmos, and an increased head circumference.
There is no syndactyly, but some nails are dysplastic.
The patient is of normal size.
Genotyping and Linkage Analysis
Sixteen polymorphic microsatellite markers from
Ge´ne´thon (Dib et al. 1996) were analyzed with eight
proximal markers—D17S1850, D17S1872, D17S927,
D17S1867, D17S1851, D17S1814, D17S800, and
D17S1787—and eight distal markers—D17S934,
D17S1861, D17S791, D17S806, D17S1795,
D17S1820, D17S809, and D17S787—with regard to
the van Buchem candidate interval between
D17S1787 and D17S934. The markers are dispersed
over a region of 120 cM. Radioactive PCRs (Hughes
1993) were done with 80 ng of genomic template and
4 pmol of each primer, in a total volume of 20 ml,
with the following conditions: 26 cycles consisting of
a 1-min denaturation step at 94C, a 1-min annealing
step at 55C, and a 1-min extension step at 72C. PCR
products were separated on a 6% polyacrylamide gel
and were analyzed after autoradiography.
Two-point LOD scores between the microsatellite
markers and the disease were calculated by the LINK-
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Figure 2 Clinical pictures of Brazilian patients with sclerosteosis. a–c, Frontal (a) and lateral b facial views and hands c of patient V-7.
d, Frontal view of patient IV-1. Both patients show facial characteristics of sclerosteosis, with a high forehead, a protruding large chin, and
facial-nerve paralysis; the hands of patients V-7 show syndactyly and nail dysplasia.
AGE software package, version 5.1 (Lathrop and Lal-
ouel 1984). MLINK two-point linkage analysis was per-
formed with parameters set for an autosomal recessive
disease with a disease frequency of 1/1,000,000 and al-
lele frequencies of 1/N,whereN is the published number
of alleles for each marker.
Results
Linkage Analysis
Initially, eight microsatellite markers localized either
centromerically (D17S1851, D17S1814, D17S800, and
Figure 3 Clinical pictures and CT scan of an American patient V-2 showing characteristics of sclerosteosis. a–b, Frontal a and lateral b
facial views. c, CT scan of posterior fossa, indicating extensive sclerosis and marked thickening of skull base, with obliteration of the diploic
space. The frontal sinuses are well developed.
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Table 1
Two-Point LOD Scores between Sclerosteosis and Markers on
Chromosome 17q12–q21
MARKER AND
POPULATION
LOD SCORE AT v
0 .01 .05 .10 .20 .30 .40
D17S1851:
Brazilian .57 .57 .52 .44 .26 .10 .01
American 2.62 2.56 2.33 2.02 1.38 .76 .26
Total 3.19 3.13 2.85 2.46 1.64 .86 .27
D17S1814:
Brazilian .53 .52 .44 .35 .17 .06 .01
American 2.12 2.06 1.82 1.52 .95 .47 .15
Total 2.65 2.58 2.26 1.87 1.12 .53 .16
D17S800:
Brazilian .72 .69 .57 .43 .21 .07 .01
American 1.28 1.25 1.12 .96 .62 .33 .12
Total 2.00 1.94 1.69 1.39 .83 .40 .13
D17S1787:
Brazilian .14 .11 .04 0 .01 .02 .03
American 1.35 1.32 1.20 1.04 .68 .37 .14
Total 1.21 1.21 1.16 1.04 .67 .35 .11
D17S934:
Brazilian .97 .94 .85 .72 .47 .26 .09
American 2.32 2.26 2.01 1.69 1.09 .56 .19
Total 3.29 3.20 2.86 2.41 1.56 .82 .28
D17S1861:
Brazilian 1.19 1.16 1.04 .89 .59 .31 .11
American 2.50 2.44 2.21 1.90 1.27 .67 .21
Total 3.69 3.60 3.25 2.79 1.86 .98 .32
D17S791:
Brazilian 1.06 1.04 .96 .84 .57 .31 .11
American 3.33 .33 .22 .34 .27 .12 .01
Total 2.27 .71 1.18 1.18 .84 .43 .12
D17S806:
Brazilian .81 .79 .68 .54 .30 .12 .01
American 4.16 .77 .16 .02 .07 .03 0
Total 3.35 .02 .52 .56 .37 .15 .01
D17S1787) and telomerically (D17S934, D17S1861,
D17S791, and D17S806) from the 0.7-cM van Buchem
linkage interval were used for two-point LOD-score cal-
culations and haplotype construction. These markers are
spread over a 7.2-cM region. Linkage analysis was per-
formed, and two-point LOD scores are listed in table 1.
For the Brazilian family, positive LOD scores were
obtained for all markers except D17S1787. A maximum
LOD score of 1.19 at 0 recombination was calculated
for D17S1861. In the American family, six of eight mi-
crosatellite markers (D17S1851, D17S1814, D17S800,
D17S1787, D17S934, and D17S1861) gave positive
LOD scores at 0 recombination, with a maximum LOD
score of 2.62 for D17S1851.
Summed LOD scores for the two families were 13 for
three of the markers—D17S1851, D17S934, and
D17S1861—with a maximum of 3.19, 3.29, and 3.69,
respectively. Except for D17S791 and D17S806, all
markers have a summed maximum LOD score at 0
recombination.
Delineation of the Candidate Region
The haplotypes from the Brazilian and American fam-
ilies with sclerosteosis are presented in figure 1. Both
patients from the Brazilian family are homozygous for
the same haplotype (fig. 1a). The obligate carriers (in-
dividuals V-2–V-6) and individual V-1 are heterozygous
for the disease-associated haplotype. Individual IV-2 car-
ries two normal haplotypes. In the American kindred
(fig. 1b), patient VI-1 shows homozygosity for all eight
markers analyzed. In patient V-2, homozygosity for the
same allele was found for all markers except D17S791
and D17S806. This confirms the presence of a recom-
bination between D17S1861 and D17S791 and localizes
the sclerosteosis gene centromerically from D17S791.
For the further delineation of the sclerosteosis can-
didate-gene interval, we analyzed eight additional mi-
crosatellites—four on the centromeric side (D17S1850,
D17S1872, D17S927, and D17S1867) and four on the
telomeric side (D17S1795, D17S1820, D17S809, and
D17S787)—from the panel of markers already analyzed.
The haplotypes for all 16 markers are given in table 2.
Two new recombinants were observed. The recombi-
nation between D17S809 and D17S787 in Brazilian pa-
tient V-7 does not result in a further refinement of the
candidate region. The recombination in American pa-
tient V-2 indicates that marker D17S791 flanks the can-
didate region on the distal side. A crossover between
D17S927 and D17S1867 in American patient VI-1 iden-
tified D17S927 as the closest flanking marker on the
proximal side. Therefore, our study delineates the can-
didate region for the sclerosteosis gene, to the 6.8-cM
region flanked by D17S927 and D17S791. This region
spans the 0.7-cM linkage interval between D17S1787
and D17S934, delineated for the van Buchem disease
gene (Van Hul et al. 1998).
Discussion
There are numerous examples of molecular geneticists
having split clinical entities on the basis of proved genetic
heterogeneity; the reverse is also true. Clinically diverse
conditions have been united by the identification of a
shared disease-causing gene (Fransen et al. 1997). It has
been well recognized that sclerosteosis and van Buchem
disease share such principal features as increased cortical
thickness of the bones, enlarged jaw, and neurological
complications due to cranial-nerve entrapment. Differ-
ential diagnosis is mainly based on the additional com-
ponents, in sclerosteosis, of gigantism and syndactyly.
Beighton et al. (1984) suggested that both conditions
could be caused by mutations in the same gene, whereby
either different mutations or epistatic influences of ad-
ditional modifying genes cause the phenotypic differ-
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Table 2
Haplotypes for 16 Chromosome 17 Markers Spanning 21.3 cM around the Linkage Interval
MARKER
GENETIC
DISTANCEa
(cM)
HAPLOTYPEb
Sclerosteosis
Brazilian Family American Family
van Buchem Disease,
Dutch Family
Patient IV-1 Patient V-7 Patient V-2 Patient VI-1 R1 R2
D17S1850 3.3 2-2 2-2 1-1 1-1 1-1 1-1
D17S1872 .5 5-5 5-5 1-1 1-2 3-2 3-3
D17S927 1.1 3-3 3-3 3-3 3-4 3-3 3-3
D17S1867 1.1 4-4 4-4 4-4 4-4 5-3 5-5
D17S1851 1.9 1-1 1-1 4-4 4-4 1-2 1-1
D17S1814 .1 2-2 2-2 4-4 4-4 2-1 2-2
D17S800 .7 3-3 3-3 3-3 3-3 1-3 1-1
D17S1787 .7 5-5 5-5 4-4 4-4 4-2 4-4
D17S934 .5 9-9 9-9 4-4 4-4 3-3 3-6
D17S1861 .7 2-2 2-2 4-4 4-4 2-2 2-8
D17S791 2.6 5-5 5-5 10-2 10-10 9-9 9-8
D17S806 1.8 2-2 2-2 9-6 9-9 1-1 1-1
D17S1795 3.3 2-2 2-2 1-5 1-1 3-3 3-6
D17S1820 1.8 7-7 7-7 2-2 2-2 4-4 5-6
D17S809 1.2 3-3 3-3 4-5 4-4 2-2 4-4
D17S787 6-6 6-3 2-9 2-5 5-5 2-6
a Between genetic marker and that in the row below (Dib et al. 1996).
b Haplotypes are those that show recombinations previously used to delineate the candidate region for the van
Buchem disease gene (Van Hul et al. 1998). Underlining denotes that the allele is different than that in the shared
haplotype.
ences. The recent localization of the van Buchem gene
between genetic markers D17S1787 and D17S934 on
chromosome 17q12–q21 (Van Hul et al. 1998) offers
the possibility for investigation of this hypothesis. The
results of our linkage study in two multiplex families
with sclerosteosis now confirm linkage of sclerosteosis
to the van Buchem locus. LOD scores 13 were obtained
with several markers on chromosome 17q, with a max-
imum of 3.69 for marker D17S1861 at 0 recombination.
A candidate region of 6.8 cM was delineated that en-
compasses the previously identified candidate region for
the van Buchem disease gene. Although the possibility
that sclerosteosis is caused by another gene localized
within the 6.8-cM candidate region cannot be excluded,
it is much more likely that our data support the hy-
pothesis of an allelic status for van Buchem disease and
sclerosteosis. Final proof, however, can be obtained only
by identification of a shared disease-causing gene.
Despite this evidence for an allelic status of the two
conditions, our study confirms the previous clinical dis-
tinction between van Buchem disease and sclerosteosis.
In both conditions, increased bone density of the skull
leads to facial paralysis and hearing loss; however, hand
abnormalities (nail dysplasia and syndactyly) are very
frequent in sclerosteosis but never are seen in patients
with van Buchem. Overall, the majority of patients with
sclerosteosis are extremely large, but, remarkably, this
is not the case in any of the Brazilian patients, one of
whom attained a height of only 1.52 m (Paes-Alves et
al. 1982). Besides these differences, sclerosteosis presents
as a more severe condition, with increased intracranial
pressure that sometimes resulted in a sudden death,
especially among the American and South African
patients.
The majority of patients with sclerosteosis are found
among the white population in South Africa. This com-
munity is of Dutch ancestry, and aDutch ancestry cannot
be excluded for the Brazilian family. The Brazilian family
lives in Tucano, a small city in the state of Bahia, ∼250
km from Salvador. Progenitors of the Brazilian com-
munity left the Netherlands during the 17th century and
settled in the bordering state of Pernambuco at the same
time that they occupied South Africa. Therefore, the pos-
sibility of a genetic link with an ancestral mutation
shared with the Dutch patients with van Buchem disease
has been suggested (Paes-Alves et al. 1982; Beighton et
al. 1984). This hypothesis would be supported by the
identification of a shared haplotype for markers close to
the disease gene. All patients with van Buchemwho have
been investigated by Van Hul et al. (1998) live in a small
ethnic isolate in the Netherlands and have a common
ancestor from the 18th century. No data are currently
available for the South African patients, but comparison
between the Brazilian and Dutch haplotypes indicates
that the putative shared region must be smaller than the
0.7 cM between D17S1787 and D17S934 (table 2). If
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it is assumed that the putative common ancestor lived
during the period of the Dutch invasion of Brazil, then
the probability that one will end up with such a small
shared region is only 7% (te Meerman et al. 1995). This
makes the hypothesis of a shared ancestor very unlikely,
but either analysis of additional microsatellite markers
or identification of the underlying mutations will even-
tually provide final evidence.
The major feature in both van Buchem disease and
sclerosteosis is increased cortical-bone density. The un-
derlying biochemical mechanism for this is unknown,
but increased bone formation has been suggested (van
Buchem et al. 1976; Stein et al. 1983). Interestingly, the
process seems to be ongoing throughout life, and the
bone tissue that is formed is of normal structure; in fact,
no bone fracture has been reported in any patient with
either van Buchem disease or sclerosteosis. All these ar-
guments support the theoretical use of the disease-caus-
ing gene or gene product as a therapeutic tool for either
the prevention of osteoporosis or the healing of bone
fractures.
In conclusion, the colocalization of the van Buchem
disease gene and the sclerosteosis gene to the same link-
age interval on chromosome 17 supports the hypothesis
that the two conditions are allelic. Unraveling of the
underlying molecular mechanisms might explain the
clinical differences between these conditions. Moreover,
the identification of the disease gene will lead to a better
understanding of the processes involved in bone ho-
meostasis and could lead to new therapeutic tools to
influence this system.
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